Tislelizumab-Associated Toxic Epidermal Necrolysis
Fields of Study & Subjects
Drug-Induced Adverse Reactions
Urticaria and Related Conditions
Autoimmune and Inflammatory Disorders
Publication details
- Journal / source
- American Journal of Therapeutics
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Volume
- 33
- Issue
- 2
- Pages
- e188–e189
- Publication date
- 1 March 2026
- Language
- EN